Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Director comp.
Credit agrmnt [a]
Acq. announced
Consulting agrmnt
Quarterly results
Horizon Therapeutics Public Ltd Co (HZNP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
10/06/2023 8-K Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Fa...
Docs: "Amended and Restated Memorandum and Articles of Association of Horizon Therapeutics plc"
10/06/2023 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
10/05/2023 8-K Other Events  Interactive Data
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Investor presentation, Quarterly results
Docs: "Horizon Therapeutics plc Reports Second-Quarter 2023 Financial Results",
"Investor Presentation of Horizon Therapeutics plc"
07/28/2023 8-K Quarterly results
06/30/2023 ARS Form ARS - Annual Report to Security Holders:
06/30/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/18/2023 8-K Other Events  Interactive Data
05/03/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/03/2023 8-K Quarterly results
04/17/2023 8-K Quarterly results
03/01/2023 10-K Annual Report for the period ended December 31, 2022
03/01/2023 8-K Quarterly results
02/24/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events  Interactive Data
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 9.4% stake in Horizon Therapeutics plc
02/09/2023 SC 13G/A FMR LLC reports a 0.1% stake in HORIZON THERAPEUTICS PLC
02/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
02/07/2023 SC 13G/A BlackRock Inc. reports a 6.5% stake in Horizon Therapeutics Public Ltd Co
01/31/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/31/2023 8-K Quarterly results
01/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
01/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy